Stroke Management: An Emerging Role of Nanotechnology
AbstractStroke is among the leading causes of mortality and morbidity worldwide. Stroke incidences and associated mortality are expected to rise to 23 million and 7.8 million, respectively, by 2030. Further, the aging population, imbalanced lifestyles, and environmental factors continue to shift the rate of stroke incidence, particularly in developing countries. There is an urgent need to develop new therapeutic approaches for treating stroke. Nanotechnology is a growing field, offering an encouraging future prospect for medical research in the management of strokes. The world market for nanotechnology derived products is expected to rise manyfold in the coming decades. Different types of nanomaterials such as perfluorocarbon nanoparticles, iron oxide nanoparticles, gold nanoparticles, polymeric nanoparticles, quantum dots, nanospheres, etc. have been developed for the diagnosis as well as therapy of strokes. Today, nanotechnology has also been integrated with stem cell therapy for treating stroke. However several obstacles remain to be overcome when using such nanomaterials for treating stroke and other neurological diseases. View Full-Text
Share & Cite This Article
Sarmah, D.; Saraf, J.; Kaur, H.; Pravalika, K.; Tekade, R.K.; Borah, A.; Kalia, K.; Dave, K.R.; Bhattacharya, P. Stroke Management: An Emerging Role of Nanotechnology. Micromachines 2017, 8, 262.
Sarmah D, Saraf J, Kaur H, Pravalika K, Tekade RK, Borah A, Kalia K, Dave KR, Bhattacharya P. Stroke Management: An Emerging Role of Nanotechnology. Micromachines. 2017; 8(9):262.Chicago/Turabian Style
Sarmah, Deepaneeta; Saraf, Jackson; Kaur, Harpreet; Pravalika, Kanta; Tekade, Rakesh K.; Borah, Anupom; Kalia, Kiran; Dave, Kunjan R.; Bhattacharya, Pallab. 2017. "Stroke Management: An Emerging Role of Nanotechnology." Micromachines 8, no. 9: 262.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.